In this study, we evaluated the anti-inflammatory activity of the soluble ethyl acetate fraction and chemical components of the stem bark of Passiflora foetida (Passifloraceae). Ten flavonoids (1-10) were isolated by various chromatographic techniques, and their structures were determined based on spectroscopic analyses by using nuclear magnetic resonance (NMR). Luteolin (2) and chrysoeriol (3) showed the most potent inhibition of nitric oxide (NO) production in macrophage cell line, RAW264.7, with half maximal inhibitor concentration (IC 50 ) values of 1.2 and 3.1 μM, respectively. These compounds suppressed lipopolysaccharide (LPS)-induced inducible NO synthase (iNOS) expression at the transcription level. Our research indicates that the stem bark of P. foetida has significant anti-inflammatory properties, suggesting that its flavonoids may have anti-inflammatory benefits.
Inflammation is a protective response that occurs following trauma, infection, tissue injury, or noxious stimuli [1a] . In this process, activated inflammatory cells, including neutrophils, eosinophils, mononuclear phagocytes, and macrophages, secrete increased amounts of nitric oxide (NO), prostaglandin E2 (PGE2), and cytokines such as interleukin (IL)-1β, IL-6, and tumor necrosis factor (TNF)-α. These substances not only induce cell and tissue damage but also activate macrophages in other diseases, including rheumatoid arthritis and chronic hepatitis [1b] . In particular, a growing body of evidence suggests that chronic inflammation can lead to cancer [1c] . NO is a major inflammatory byproduct, and its production is controlled by nitric oxide synthases (NOS), which include inducible NOS (iNOS), endothelial NOS (eNOS), and neuronal NOS (nNOS). Importantly, iNOS is highly expressed in macrophages, and its activation leads to organ destruction in some inflammatory and autoimmune diseases [1d] . During inflammation, macrophages play a central role in managing many immunepathological phenomena, including the overproduction of proinflammatory cytokines and inflammatory mediators, such as IL-1β, IL-6, NO, iNOS, cyclooxygenase (COX)-2, and TNF-α. Indeed, a number of inflammatory stimuli, such as lipopolysaccharide (LPS) and pro-inflammatory cytokines, activate immune cells to upregulate such inflammatory states. The overproduction of NO by iNOS has been implicated in the pathology of several inflammatory disorders, including septic shock, tissue damage after inflammation, and rheumatoid arthritis [1e-1g]. Thus, LPS-induced, iNOSmediated NO production may reflect the degree of inflammation, and changes in NO levels through the inhibition of iNOS activity could represent a novel method to assess the anti-inflammatory effects of novel compounds.
Our lab has sought to identify the inflammatory inhibitors from natural sources, and we recently determined that the methanol extract of Passiflora foetida (Passifloraceae) has appreciable inhibitory activity. The crushed fruit juices have been used as an antianxiety therapeutic for many years [2a] . In addition, numerous studies have reported that the aqueous and organic extracts of P. foetida leaves and fruits have numerous biological effects, including antibacterial, antioxidant, and anti-inflammatory activities and can be applied to treat various symptoms, such as hysteria, insomnia, headaches, and asthma [2b-2e] . However, the anti-inflammatory effects of the stem bark constituents remain unclear. Thus, we describe the physical chemistry of the isolates and their isolation, and evaluated their effect on inflammation. The stem bark methanolic (MeOH) extract of P. foetida was partitioned into nhexane-, chloroform (CHCl 3 -), ethyl acetate (EtOAc)-, n-BuOH (nbutanol-), and water-soluble fractions. In a preliminary experiment, the anti-inflammatory effects of these fractions were evaluated by using varying concentrations (0-30 μg/mL). The EtOAc fraction showed the greatest inhibitory activity and was selected for further isolation of the active components by bioactivity-guided fractionation. Chromatographic purification of the EtOAc fraction led to the isolation of ten compounds (1-10) (Figure 1 ). 
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The structures of these compounds were determined to be apigenin (1), luteolin (2), chrysoeriol (3), tricin (4), quercetin-4'-methyl ether (5), vitexin (6), vitexin-2"-O-xyloside (7), orientin (8), apigenin 7-O-β-D-glucopyranoside (9), and luteolin 7-O-β-D-glucopyranoside (10) by comparing their physical and spectroscopic data with previous data [2f-2l].
The cytotoxic effects of the isolated compounds (1-10) were evaluated by {3-(4,5-dimethylthaizol-2-yl)-2-5-diphenyltetrazolium bromide (MTT)} assay. The compounds did not affect the viability of RAW 264.7 macrophage cells after 24 h treatment in either the presence or absence of LPS, even at a dose of 30 μM (data not shown). In RAW 264.7 cells, LPS stimulation can induce iNOS transcription and protein synthesis and subsequent NO production [3a] . Therefore this cell system is an excellent model to evaluate topical agents and screen potential inhibitors of the iNOS pathway and NO production [3b] . To evaluate the effect of compounds 1-10 on NO production, the Griess assay was performed [3c] . As shown in Table 1 , compounds 1-3 inhibited NO production, with half maximal inhibitor concentration (IC 50 ) values of 6.5, 1.2, and 3.1 μM, respectively. Compound 4 had a moderate effect on NO production, with an IC 50 value of 28.0 μM; however, the other compounds were inactive. Western blot analysis was performed to determine the inhibitory effects of compounds 2 and 3 on iNOS expression. These compounds (0-10 μM) dose-dependently reduced LPS-induced iNOS expression, but did not alter α-tubulin expression, suggesting that compounds 2 and 3 inhibited iNOS activity in LPS-stimulated RAW264.7 cells (Figure 2 ). While a small amount of NO synthesized by eNOS and nNOS is essential for maintaining homeostasis, the significantly higher amount of NO synthesized by iNOS synergistically promotes inflammatory processes in conjunction with other inflammatory mediators [4a] . Thus, the inhibition of iNOS activity or downregulation of iNOS expression could be beneficial to inhibit inflammatory responses. Based on these results, flavonoid glycosides (5-10) did not significantly inhibit NO production at 30 µM, regardless of the aglycones (flavone, flavonol) present and the glycoside linkages (C-or O-glycosides) . Some flavones/flavonols, mainly flavones (1-4), significantly inhibited NO production. In general, flavones showed stronger inhibition of NO production than flavonols (Table 1) . Luteolin (2) was the most active inhibitor among the flavonoids tested. These results strongly suggest that the C-2,3 double bond is crucial for inhibiting NO production, and the hydroxyl substitutions on the A-and B-ring influence the inhibitory activity. A-ring 5-/7-and B-ring 3-/4-hydroxylation(s) gave favorable results, while C-3 hydroxylation (flavonol) did not. We also demonstrated that the active flavonoids did not significantly inhibit iNOS activity [4b] . These findings were consistent with a study that showed luteolin, apigenin, and chrysoeriol inhibited NO production via iNOS down-regulation [4c]. Flavanone derivatives, which do not have a C-2,3 double bond, were inactive up to 30 µM. These results indicated that a planar ring system in the flavonoid molecule is important for NO inhibition [4d] . Following these investigations, many researchers reported similar properties of various flavonoids. They included flavones such as apigenin and oroxylin A, flavonols such as kaempferol and quercetin, bioflavonoids such as bilobetin and ginkgetin, and some prenylated flavonoids, including sanggenons and kuwanon C. Interestingly, some prenylated flavonoids inhibited LPS-induced NO production in RAW 264.7 cells by inducing cytotoxicity, because prenylated flavonoids were toxic at doses higher than 50 mM [4e]. Thus, it is possible that the inhibition of NO production by these flavonoids may be due, in part, to their reduction of iNOS expression. In conclusion, certain flavonoids, especially flavones such as luteolin, inhibited NO production in LPS-stimulated RAW 264.7 cells in vitro. Inhibition of NO production may contribute to the antiinflammatory and immunoregulatory activity of flavonoids.
Experimental
Plant material: The stem bark of P. foetida was collected in November, 2011 in Cao Bang province, Northern Vietnam. The sample was authenticated by Professor Vu Xuan Phuong, and the voucher specimen was deposited at the Herbarium of the Institute of Ecology and Biological Resources, Vietnam Academy of Science and Technology.
Extraction and isolation:
The stem bark of P. foetida (4.0 kg) was extracted by refluxing with methanol (3 times × 3 L). After the solvent was removed under reduced pressure, the residue was suspended in water and partitioned with n-hexane, CHCl 3 , EtOAc, and n-BuOH, successively. Using activity-guided fractionation, the EtOAc soluble fraction (17.0 g) was resolved by silica gel column chromatography (CC), eluting with a gradient of CHCl 3 -MeOH (30:1→1:1), to obtain 14 fractions (Fr.E1-E14). Compound 5 was obtained as crystals in methanol by collecting the EtOAc soluble fraction. Fraction E3 (204.7 mg) was subjected to RP-C18 silica gel CC and eluted with MeOH-H 2 O (1:3→9:1) to afford 10 subfractions (Fr.E3-1-E3-10). Further purification of Fr.E3-8 (170 mg) by using Sephadex LH-20 silica gel CC and eluting with MeOH-H 2 O (2:1→4:1) yielded compounds 3 (5.6 mg) and 4 (6.1 mg). From fraction E4 (510.6 mg), 7 sub-fractions (Fr.E4-1~E4-7) were obtained by using C-18 silica gel CC with gradient MeOH-H 2 O (1:3→1:2) elution. Further purification of E4-7 (80 mg) by Sephadex LH-20 gel CC eluted with MeOH-H 2 O (1:1→3:1) resulted in compound 2 (13.0 mg). Sub-fraction E4-5 (46.7 mg) underwent medium pressure liquid chromatography (MPLC) on an octadecyl silica (ODS) gel column chromatograph by using a gradient of MeOH-H 2 O (1:3→1:1) to obtain compound 10 (4.5 mg). From fraction E5 (3.5 g), 14 sub-fractions (Fr. E5-1-E5-14) were obtained after RP-C18 silica gel CC and elution with MeOH-H 2 O (1:4→1:1). Compound 1 (6.0 mg) was obtained by purifying sub-fraction E5-14 (40.0 mg) by using Sephadex LH-20 gel CC eluted with MeOH-H 2 O (1:2→2:1). Fraction E6 (1.01 g) was subjected to silica gel CC and elution with a gradient of n-hexaneacetone (7:1→3:5), yielding 3 sub-fractions (Fr.E6-1-E6-3). Subfraction E6-1 (196 mg) underwent MPLC by using an Ultra pack, ODS-S-50A column. Using a mobile phase consisting of methanol in water (1:3→3:2), compounds 8 (13.2 mg) and 9 (7.2 mg) were obtained. Fraction E7 (153.8 g) was subjected to silica gel cc and eluted with CH 2 Cl 2 -EtOAc-H+ (9:1:0.05→1:1: 0.05) to obtain 9 sub-fractions (Fr. E7.1~E7.9). Compounds 6 (4.5 mg, tR = 30.5 min) and 7 (8.7 mg, tR = 39.8 min) were obtained from sub-fraction E7.1 (85 mg) by semi-preparative HPLC, by using a gradient of acetonitrile (ACN)-H 2 O (15:85→25: 75) over 60 min, a flow rate of 5 mL/min, UV detection at 280 and 330 nm, and a YMC-pack-ODS-A column (20 × 250 mm, 5 µm).
Determination of NO production and cell viability: The level of NO production was determined by measuring the amount of nitrite present in the cell culture supernatants, as described previously [3c] . Briefly, RAW 264.7 cells (1 × 10 5 cells/well) were stimulated in the presence or absence of 1 μg/mL LPS (Sigma Chemical Co.; St. Louis, MO, USA) for 24 h, with or without the test compounds (0.5−30 μM). The cell culture supernatant (100 μL) was then reacted with 100 μL Griess reagent (1% sulfanilamide in 5% phosphoric acid and 0.1% naphthylethylenediamine dihydrochloride in distilled H 2 O). The absorbance at 540 nm was determined by microplate reader (Molecular Devices, Emax, Sunnyvale, CA, USA), and the absorption coefficient was calibrated by using a sodium nitrite (NaNO 2 ) solution standard. Cell viability was measured with the MTT-based colorimetric assay. For this experiment, celastrol was used as a positive control [3c].
Immunoblot analysis: Proteins were extracted from cells in icecold lysis buffer (50 mM Tris-HCl, pH 7.5, 1% Nonidet P-40, 1 mM ethylenediaminetetraacetic acid, EDTA; 1 mM phenylmethylsulfonyl fluoride, 1 μg/mL leupeptin, 1 mM sodium vanadate, and 150 mM sodium chloride, NaCl). Proteins (50 μg) were loaded to each lane for separation by sodium dodecyl sulfatepolyacrylamide gel electrophoresis and transferred to a polyvinylidene difluoride membrane (Millipore, Bedford, MA, USA). The membrane was blocked with 5% skim milk and then incubated with the corresponding antibody. The antibody for iNOS was obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). The antibody for α-tubulin was obtained from Sigma. After binding of an appropriate secondary antibody coupled to horseradish peroxidase, proteins were visualized by enhanced chemiluminescence according to the manufacturer's instructions (Amersham Pharmacia Biotec; Buckinghamshire, UK) [3c].
Statistical analysis:
Values are expressed as mean ± S.E.M.
